Suppr超能文献

胶质母细胞瘤瘤周组织的基因表达谱:一项离体研究。

Gene expression profile of glioblastoma peritumoral tissue: an ex vivo study.

机构信息

Institute of Neurosurgery, Faculty of Medicine, Catholic University of Rome, Rome, Italy.

出版信息

PLoS One. 2013;8(3):e57145. doi: 10.1371/journal.pone.0057145. Epub 2013 Mar 5.

Abstract

The gene expression pattern of glioblastoma (GBM) is well documented but the expression profile of brain adjacent to tumor is not yet analysed. This may help to understand the oncogenic pathway of GBM development. We have established the genome-wide expression profiles of samples isolated from GBM tumor mass, white matter adjacent to tumor (apparently free of tumor cells), and white matter controls by using the Affymetrix HG-U133 arrays. Array-CGH (aCGH) was also performed to detect genomic alterations. Among genes dysregulated in peritumoral white matter, 15 were over-expressed, while 42 were down-regulated when compared to white matter controls. A similar expression profile was detected in GBM cells. Growth, proliferation and cell motility/adhesion-associated genes were up-regulated while genes involved in neurogenesis were down-regulated. Furthermore, several tumor suppressor genes along with the KLRC1 (a member of natural killer receptor) were also down-regulated in the peritumoral brain tissue. Several mosaic genomic lesions were detected by aCGH, mostly in tumor samples and several GBM-associated mosaic genomic lesions were also present in the peritumoral brain tissue, with a similar mosaicism pattern. Our data could be explained by a dilution of genes expressed from tumor cells infiltrating the peritumour tissue. Alternatively, these findings could be substained by a relevant amount of "apparently normal" cells presenting a gene profile compatible with a precancerous state or even "quiescent" cancer cells. Otherwise, the recurrent tumor may arise from both infiltrating tumor cells and from an interaction and recruitment of apparently normal cells in the peritumor tissue by infiltrating tumor cells.

摘要

胶质母细胞瘤(GBM)的基因表达模式已有详细记录,但肿瘤旁脑组织的表达谱尚未分析。这有助于了解 GBM 发展的致癌途径。我们使用 Affymetrix HG-U133 芯片,建立了从 GBM 肿瘤组织、肿瘤旁白质(明显无肿瘤细胞)和白质对照样本中分离的全基因组表达谱。还进行了 array-CGH(aCGH)以检测基因组改变。与白质对照相比,肿瘤旁白质中失调的基因中有 15 个上调,42 个下调。在 GBM 细胞中也检测到类似的表达谱。与生长、增殖和细胞迁移/黏附相关的基因上调,而与神经发生相关的基因下调。此外,在肿瘤旁脑组织中还下调了几个肿瘤抑制基因以及 KLRC1(自然杀伤受体的一个成员)。aCGH 检测到几个镶嵌基因组病变,主要在肿瘤样本中,几个与 GBM 相关的镶嵌基因组病变也存在于肿瘤旁脑组织中,具有相似的镶嵌模式。我们的数据可以通过浸润肿瘤组织的肿瘤细胞表达的基因稀释来解释。或者,这些发现可能由浸润肿瘤组织中存在的大量“看似正常”细胞表达与癌前状态或甚至“静止”癌细胞相容的基因谱来支持。否则,复发性肿瘤可能源自浸润肿瘤细胞以及浸润肿瘤细胞与肿瘤旁组织中“看似正常”细胞的相互作用和募集。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b241/3589444/d92d6cd91abc/pone.0057145.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验